Market closed
OrthoPediatrics/$KIDS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OrthoPediatrics
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Ticker
$KIDS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
562
Website
OrthoPediatrics Metrics
BasicAdvanced
$609M
-
-$1.64
1.22
-
Price and volume
Market cap
$609M
Beta
1.22
52-week high
$35.99
52-week low
$21.02
Average daily volume
285K
Financial strength
Current ratio
6.983
Quick ratio
3.274
Long term debt to equity
22.238
Total debt to equity
22.283
Interest coverage (TTM)
-11.26%
Management effectiveness
Return on assets (TTM)
-4.05%
Return on equity (TTM)
-10.34%
Valuation
Price to revenue (TTM)
2.827
Price to book
1.71
Price to tangible book (TTM)
3.38
Price to free cash flow (TTM)
-14.011
Growth
Revenue change (TTM)
37.65%
Earnings per share change (TTM)
77.30%
3-year revenue growth (CAGR)
27.81%
3-year earnings per share growth (CAGR)
24.79%
What the Analysts think about OrthoPediatrics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for OrthoPediatrics stock.
OrthoPediatrics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OrthoPediatrics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OrthoPediatrics News
AllArticlesVideos
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewsWire·2 weeks ago
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OrthoPediatrics stock?
OrthoPediatrics (KIDS) has a market cap of $609M as of March 17, 2025.
What is the P/E ratio for OrthoPediatrics stock?
The price to earnings (P/E) ratio for OrthoPediatrics (KIDS) stock is 0 as of March 17, 2025.
Does OrthoPediatrics stock pay dividends?
No, OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders as of March 17, 2025.
When is the next OrthoPediatrics dividend payment date?
OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders.
What is the beta indicator for OrthoPediatrics?
OrthoPediatrics (KIDS) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.